Follow
Eszter Lazar-Molnar
Eszter Lazar-Molnar
Assistant Professor of Pathology, University of Utah School of Medicine
Verified email at path.utah.edu
Title
Cited by
Cited by
Year
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
KC Ohaegbulam, A Assal, E Lazar-Molnar, Y Yao, X Zang
Trends in molecular medicine 21 (1), 24-33, 2015
8852015
Autocrine and paracrine regulation by cytokines and growth factors in melanoma
E Lázár-Molnár, H Hegyesi, S Tóth, A Falus
Cytokine 12 (6), 547-554, 2000
5652000
Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis
E Lázár-Molnár, B Chen, KA Sweeney, EJ Wang, W Liu, J Lin, SA Porcelli, ...
Proceedings of the National Academy of Sciences 107 (30), 13402-13407, 2010
3422010
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
E Lázár-Molnár, Q Yan, E Cao, U Ramagopal, SG Nathenson, SC Almo
Proceedings of the National Academy of Sciences 105 (30), 10483-10488, 2008
2732008
The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum
E Lázár-Molnár, A Gácser, GJ Freeman, SC Almo, SG Nathenson, ...
Proceedings of the National Academy of Sciences 105 (7), 2658-2663, 2008
1312008
A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens
P Arora, A Baena, OA Karl, NK Saini, SS Kharkwal, MF Goldberg, ...
Immunity 40 (1), 105-116, 2014
1302014
Sequence, structure, function, immunity: structural genomics of costimulation
K Chattopadhyay, E Lazar‐Molnar, Q Yan, R Rubinstein, C Zhan, ...
Immunological reviews 229 (1), 356-386, 2009
1212009
Structure and T cell inhibition properties of B7 family member, B7-H3
V Vigdorovich, UA Ramagopal, E Lázár-Molnár, E Sylvestre, JS Lee, ...
Structure 21 (5), 707-717, 2013
1152013
Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation
A Falus, H Hegyesi, E Lázár-Molnár, Z Pós, V László, Z Darvas
Trends in immunology 22 (12), 648-652, 2001
742001
Tissue-expressed B7-H1 critically controls intestinal inflammation
L Scandiuzzi, K Ghosh, KA Hofmeyer, YM Abadi, E Lázár-Molnár, EY Lin, ...
Cell reports 6 (4), 625-632, 2014
712014
Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy
E Lázár-Molnár, L Scandiuzzi, I Basu, T Quinn, E Sylvestre, E Palmieri, ...
EBioMedicine 17, 30-44, 2017
632017
Autoimmune NMDA receptor encephalitis
E Lazar-Molnar, AE Tebo
Clinica chimica acta 438, 90-97, 2015
632015
Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin‐6
E Lázár‐Molnár, H Hegyesi, E Pállinger, P Kovács, S Tóth, C Fitzsimons, ...
European journal of clinical investigation 32 (10), 743-749, 2002
602002
A Monoclonal Antibody to Histoplasma capsulatum Alters the Intracellular Fate of the Fungus in Murine Macrophages
L Shi, PC Albuquerque, E Lazar-Molnar, X Wang, L Santambrogio, ...
Eukaryotic cell 7 (7), 1109-1117, 2008
422008
Histamine deficiency induces tissue-specific down-regulation of histamine H2 receptor expression in histidine decarboxylase knockout mice
CP Fitzsimons, E Lazar-Molnar, Z Tomoskozi, E Buzás, ES Rivera, ...
FEBS letters 508 (2), 245-248, 2001
382001
The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function
E Lazar-Molnar, SC Almo, SG Nathenson
Cellular immunology 244 (2), 125-129, 2006
342006
HLA genotyping in the clinical laboratory: comparison of next‐generation sequencing methods
T Profaizer, E Lázár‐Molnár, DW Close, JC Delgado, A Kumánovics
Hla 88 (1-2), 14-24, 2016
312016
Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line
N Szincsak, H Hegyesi, J Hunyadi, G Martin, E Lazar-Molnar, P Kovacs, ...
Melanoma Research 12 (3), 231-240, 2002
312002
Immunogenicity assessment of tumor necrosis factor antagonists in the clinical laboratory
E Lazar-Molnar, JC Delgado
Clinical chemistry 62 (9), 1186-1198, 2016
282016
Clinical laboratory application of a reporter-gene assay for measurement of functional activity and neutralizing antibody response to infliximab
IY Pavlov, J Carper, E Lázár-Molnár, JC Delgado
Clinica Chimica Acta 453, 147-153, 2016
262016
The system can't perform the operation now. Try again later.
Articles 1–20